Andreia Neves-Carvalho Selected Research

Neurodegenerative Diseases (Neurodegenerative Disease)

1/2024	Glucocorticoid receptor-dependent therapeutic efficacy of tauroursodeoxycholic acid in preclinical models of Spinocerebellar ataxia type 3.
6/2023	Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IP3R2) Fails to Modify Disease Progression in a Mouse Model of Spinocerebellar Ataxia Type 3.
1/2022	Profiling Microglia in a Mouse Model of Machado-Joseph Disease.
1/2018	Neuroprotective Effects of Creatine in the CMVMJD135 Mouse Model of Spinocerebellar Ataxia Type 3.
11/2015	Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease.
12/2014	Lithium chloride therapy fails to improve motor function in a transgenic mouse model of Machado-Joseph disease.
9/2009	ATX-3, CDC-48 and UBXN-5: a new trimolecular complex in Caenorhabditis elegans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreia Neves-Carvalho Research Topics

Disease

13	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2024 - 09/2009
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 09/2009
4	Disease Progression 01/2024 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 11/2014
2	Gliosis 01/2018 - 11/2015
1	Ataxia (Dyssynergia) 11/2021
1	Wounds and Injuries (Trauma) 03/2021
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 11/2020
1	Tauopathies 01/2019
1	Movement Disorders (Movement Disorder) 01/2018
1	Body Weight (Weight, Body) 11/2015
1	Tremor (Tremors) 12/2014
1	Hyperalgesia 11/2014
1	Pain (Aches) 11/2014

Drug/Important Bio-Agent (IBA)

8	Ataxin-3IBA 01/2024 - 09/2009
7	polyglutamineIBA 01/2024 - 09/2009
5	Proteins (Proteins, Gene)FDA Link 11/2020 - 09/2009
3	EnzymesIBA 01/2024 - 04/2011
2	Polynucleotide 5'-Hydroxyl-Kinase (Kinase, Polynucleotide)IBA 01/2024 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2015
2	tau Proteins (tau Protein)IBA 01/2019 - 11/2014
2	Neuroprotective AgentsIBA 01/2018 - 12/2014
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Bile Acids and Salts (Bile Acids)IBA 01/2024
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2024
1	ursodoxicoltaurineIBA 01/2024
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 06/2023
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2022
1	Levetiracetam (Keppra)FDA LinkGeneric 03/2021
1	CalbindinsIBA 01/2018
1	CreatineIBA 01/2018
1	Citalopram FDA LinkGeneric 11/2015
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2015
1	Beclin-1IBA 12/2014
1	Lithium ChlorideIBA 12/2014
1	LithiumIBA 12/2014
1	Formaldehyde (Formol)FDA Link 11/2014
1	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 04/2014
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2011
1	UbiquitinIBA 04/2011

Therapy/Procedure

2	Therapeutics 11/2021 - 12/2014
1	Transplantation 11/2021